Wan Li, Huang Jingyong, Ni Haizhen, Yu Guanfeng
Department of pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Department of vascular surgery, The First Affiliated Hospital of Wenzhou Medical University, NO.3, YuanXi Lane, Lucheng District, Wenzhou, Zhejiang, 325000, China.
BMC Cardiovasc Disord. 2018 Feb 13;18(1):34. doi: 10.1186/s12872-018-0766-8.
Abdominal aortic aneurysm (AAA) is a common cardiovascular system disease with high mortality. The aim of this study was to identify potential genes for diagnosis and therapy in AAA.
We searched and downloaded mRNA expression data from the Gene Expression Omnibus (GEO) database to identify differentially expressed genes (DEGs) from AAA and normal individuals. Then, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis, transcriptional factors (TFs) network and protein-protein interaction (PPI) network were used to explore the function of genes. Additionally, immunohistochemical (IHC) staining was used to validate the expression of identified genes. Finally, the diagnostic value of identified genes was accessed by receiver operating characteristic (ROC) analysis in GEO database.
A total of 1199 DEGs (188 up-regulated and 1011 down-regulated) were identified between AAA and normal individual. KEGG pathway analysis displayed that vascular smooth muscle contraction and pathways in cancer were significantly enriched signal pathway. The top 10 up-regulated and top 10 down-regulated DEGs were used to construct TFs and PPI networks. Some genes with high degrees such as NELL2, CCR7, MGAM, HBB, CSNK2A2, ZBTB16 and FOXO1 were identified to be related to AAA. The consequences of IHC staining showed that CCR7 and PDGFA were up-regulated in tissue samples of AAA. ROC analysis showed that NELL2, CCR7, MGAM, HBB, CSNK2A2, ZBTB16, FOXO1 and PDGFA had the potential diagnostic value for AAA.
The identified genes including NELL2, CCR7, MGAM, HBB, CSNK2A2, ZBTB16, FOXO1 and PDGFA might be involved in the pathology of AAA.
腹主动脉瘤(AAA)是一种常见的心血管系统疾病,死亡率很高。本研究的目的是鉴定AAA诊断和治疗的潜在基因。
我们从基因表达综合数据库(GEO)中搜索并下载mRNA表达数据,以鉴定AAA患者和正常个体之间的差异表达基因(DEG)。然后,使用基因本体论和京都基因与基因组百科全书通路分析、转录因子(TF)网络和蛋白质-蛋白质相互作用(PPI)网络来探索基因的功能。此外,采用免疫组织化学(IHC)染色来验证所鉴定基因的表达。最后,通过GEO数据库中的受试者工作特征(ROC)分析评估所鉴定基因的诊断价值。
在AAA患者和正常个体之间共鉴定出1199个DEG(188个上调和1011个下调)。KEGG通路分析显示,血管平滑肌收缩和癌症相关通路是显著富集的信号通路。使用上调排名前10和下调排名前10的DEG构建TF和PPI网络。鉴定出一些高连接度的基因,如NELL2、CCR7、MGAM、HBB、CSNK2A2、ZBTB16和FOXO1与AAA相关。IHC染色结果显示,CCR7和PDGFA在AAA组织样本中上调。ROC分析显示,NELL2、CCR7、MGAM、HBB、CSNK2A2、ZBTB16、FOXO1和PDGFA对AAA具有潜在诊断价值。
所鉴定的基因包括NELL2、CCR7、MGAM、HBB、CSNK2A2、ZBTB16、FOXO1和PDGFA可能参与了AAA的病理过程。